Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
26%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
XBI
143
HOLDINGS
15%
ALSO IN PBE
PBE
33
HOLDINGS
76%
ALSO IN XBI
SECTOR DRIFT (XBI minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 1.8% | 4.9% | 1.8% |
|
HALOZYME THERAPEUTICS INC | 1.8% | 2.6% | 1.8% |
|
UNITED THERAPEUTICS CORP | 1.8% | 4.5% | 1.8% |
|
AMGEN INC | 1.7% | 4.9% | 1.7% |
|
EXELIXIS INC | 1.7% | 2.7% | 1.7% |
XBI Overweight Relative to PBE
|
MODERNA, INC. | 2.2% |
|
NATERA INC | 1.9% |
|
ABBVIE INC | 1.7% |
|
TWIST BIOSCIENCE CORP. | 1.7% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.6% |
|
SPYRE THERAPEUTICS INC | 1.6% |
|
TG THERAPEUTICS INC | 1.5% |
 |
ALKERMES PLC | 1.5% |
|
CRISPR THERAPEUTICS AG | 1.4% |
|
BRIDGEBIO PHARMA, INC. | 1.4% |
XBI Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -4.8% |
|
VERTEX PHARMACEUTICALS INC | -3.5% |
|
ALNYLAM PHARMACEUTICALS INC | -3.3% |
|
BIO-TECHNE CORPORATION | -3.2% |
|
AMGEN INC | -3.2% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
BIOGEN IDEC INC | -3.1% |
|
REPLIGEN CORP | -3.0% |
|
ILLUMINA INC | -3.0% |
|
GILEAD SCIENCES INC | -2.9% |